CHMP summary of positive opinion for Fabhalta
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
CHMP summary of positive opinion for Fabhalta
Summary of opinion: Nilemdo, 21/03/2024 Positive
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Summary of opinion: Nilemdo, 21/03/2024 Positive
First oral monotherapy for patients with paroxysmal nocturnal haemoglobinuria
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
First oral monotherapy for patients with paroxysmal nocturnal haemoglobinuria
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 March 2024
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 18-21 March 2024
Summary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positive
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Summary of opinion: Onivyde pegylated liposomal (previously known as Onivyde), 21/03/2024 Positive
Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Status: Opinion
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Human medicines European public assessment report (EPAR): Dimethyl fumarate Mylan, dimethyl fumarate, Status: Opinion
Summary of opinion: Nustendi, 21/03/2024 Positive
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Summary of opinion: Nustendi, 21/03/2024 Positive
New antibiotic to fight infections caused by multidrug-resistant bacteria
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
New antibiotic to fight infections caused by multidrug-resistant bacteria
Summary of opinion: Bimzelx, 21/03/2024 Positive
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Summary of opinion: Bimzelx, 21/03/2024 Positive
Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Status: Opinion
Submitted by Anonymous (not verified) on 22 March 2024 - 11:00
Human medicines European public assessment report (EPAR): Dimethyl fumarate Accord, dimethyl fumarate, Status: Opinion